Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-25-000448
Filing Date
2025-01-21
Accepted
2025-01-21 08:20:21
Documents
1
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2133
  Complete submission text file 0001683168-25-000448.txt   3904
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address
Roy Michel (Reporting) CIK: 0002052644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41282 | Film No.: 25540509